-
Mashup Score: 3
This cross-sectional study uses US commercial health insurance claims data to assess mental health care utilization among parents of children with vs without cancer.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6
Story at a glance Cervical cancer rates in the United States have been declining overall for years. A recent study, however, found that rates of the disease are rising among low-income women, parti…
Source: thehill.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Study Reinforces Link Between Mobile Phone Addiction and Insomnia - 1 month(s) ago
A cross-sectional study utilizing self-reports from Chinese college students correlated mobile phone use with insomnia, bolstering previous research that made similar conclusions.
Source: www.ajmc.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Updated COVID-19 shots lower hospitalization risk in immunocompromised people by a third - 1 month(s) ago
Receipt of an updated COVID-19 vaccine lowered the risk for hospitalization among immunocompromised people by around one-third, according to a study.
Source: www.healio.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Up to 30 Percent of CVD Mortality Attributable to Excess Salt Intake - 1 month(s) ago
FRIDAY, March 29, 2024 (HealthDay News) — Excess sodium intake is associated with 10 to 30 percent of cardiovascular disease (CVD) mortality, according to a st
Source: www.healthday.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5Normal Risk Ovarian Screening Study: 21-Year Update - 1 month(s) ago
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported. PURPOSE The Normal Risk Ovarian Screening Study (NROSS) tested a two-stage screening strategy in postmenopausal women at conventional hereditary risk where significantly rising cancer antigen (CA)-125 prompted transvaginal sonography (TVS) and abnormal TVS prompted surgery to detect ovarian cancer. METHODS A total of 7,856 healthy postmenopausal women were screened annually for a total of 50,596 woman-years in a single-arm study (ClinicalTrials.gov identifier: NCT00539162). Serum CA125 was analyzed with the Risk of Ovarian Cancer Algorithm (ROCA) each year. If risk was u
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age - 1 month(s) ago
A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Source: www.ajmc.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5Normal Risk Ovarian Screening Study: 21-Year Update - 1 month(s) ago
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported. PURPOSE The Normal Risk Ovarian Screening Study (NROSS) tested a two-stage screening strategy in postmenopausal women at conventional hereditary risk where significantly rising cancer antigen (CA)-125 prompted transvaginal sonography (TVS) and abnormal TVS prompted surgery to detect ovarian cancer. METHODS A total of 7,856 healthy postmenopausal women were screened annually for a total of 50,596 woman-years in a single-arm study (ClinicalTrials.gov identifier: NCT00539162). Serum CA125 was analyzed with the Risk of Ovarian Cancer Algorithm (ROCA) each year. If risk was u
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5Normal Risk Ovarian Screening Study: 21-Year Update - 1 month(s) ago
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported. PURPOSE The Normal Risk Ovarian Screening Study (NROSS) tested a two-stage screening strategy in postmenopausal women at conventional hereditary risk where significantly rising cancer antigen (CA)-125 prompted transvaginal sonography (TVS) and abnormal TVS prompted surgery to detect ovarian cancer. METHODS A total of 7,856 healthy postmenopausal women were screened annually for a total of 50,596 woman-years in a single-arm study (ClinicalTrials.gov identifier: NCT00539162). Serum CA125 was analyzed with the Risk of Ovarian Cancer Algorithm (ROCA) each year. If risk was u
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5Normal Risk Ovarian Screening Study: 21-Year Update - 1 month(s) ago
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported. PURPOSE The Normal Risk Ovarian Screening Study (NROSS) tested a two-stage screening strategy in postmenopausal women at conventional hereditary risk where significantly rising cancer antigen (CA)-125 prompted transvaginal sonography (TVS) and abnormal TVS prompted surgery to detect ovarian cancer. METHODS A total of 7,856 healthy postmenopausal women were screened annually for a total of 50,596 woman-years in a single-arm study (ClinicalTrials.gov identifier: NCT00539162). Serum CA125 was analyzed with the Risk of Ovarian Cancer Algorithm (ROCA) each year. If risk was u
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
Parents of children with #cancer made mental health visits more often than other parents https://t.co/IS0npq5rin